United Kingdom· GB-APID-10576711000001100
K-Phos Neutral tablets
A medicinal product containing disodium hydrogen phosphate anhydrous, registered in United Kingdom by Imported (United States).
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Disodium hydrogen phosphate anhydrous
- Manufacturer
- Imported (United States)
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Disodium hydrogen phosphate anhydrous in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d67e4eae-cce3-4344-b922-15d02a39976d GET /v1/drugs/d67e4eae-cce3-4344-b922-15d02a39976d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "10576711000001100",
"desc": "K-Phos Neutral tablets (Imported (United States))",
"form": "Oral tablet",
"vpid": "10576311000001104",
"source": "dmd",
"vtm_id": null,
"strength": "852 mg",
"substance": null,
"ingredient": "Disodium hydrogen phosphate anhydrous",
"supplier_code": "11821411000001108"
}See everything about disodium hydrogen phosphate anhydrous.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.